SourcesDrugs.com. “Methadone.” August 2019. Accessed August 2, 2019.
MedlinePlus. “Methadone overdose.” September 2017. Accessed August 2, 2019.
World Health Organization. “Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings: Methadone Maintenance Treatment.” 2009. Accessed August 2, 2019.
Fenn, Jennifer M.; Laurent, Jennifer S.; Sigmon, Stacey C. “Increases in body mass index following initiation of methadone treatment.” The Journal of Substance Abuse Treatment, November 2014. Accessed August 2, 2019.
Mysels, David J.; Sullivan, Maria A. “The relationship between opioid and sugar intake: Review of evidence and clinical applications.” The Journal of Opioid Management, December 2010. Accessed August 2, 2019.
Holzer, Peter. “Opioid receptors in the gastrointestinal tract.” Regulatory Peptides, June 2009. Accessed August 2, 2019.
Sizar, Omeed; Gupta, Mohit. “Opioid Induced Constipation.” NCBI StatPearls, June 2019. Accessed August 2, 2019.
Wang, David; Teichtahl, Harry; Goodman, Cathy; Drummer, Olaf; Grunstein, Ronald R.; Kronborg, Ian. “Subjective Daytime Sleepiness and Daytime Function in Patients on Stable Methadone Maintenance Treatment: Possible Mechanisms.” Journal of Clinical Sleep Medicine, May 2008. Accessed August 2, 2019.
Lee, Angela S.; Twigg, Stephen M. “Opioid-induced secondary adrenal insufficiency presenting as hypercalcaemia.” Endocrinology, Diabetes & Metabolism Case Reports, June 2015. Accessed August 2, 2019.
Green, Robert; Pynn, Bruce R. “Methadone: A Review.” Oral Health, June 2011. Accessed August 2, 2019.
University of Maryland. “Methadone.” Center for Substance Abuse Research, January 2016. Accessed August 2, 2019.
Motlagh, Farid; Ibrahim, Fatimah; Rashid, Rusdi; Shafiabady, Niusha; Seghatoleslam, Tahereh; Habil, Hussain. “Acute effects of methadone on EEG power spectrum and event-related potentials among heroin dependents.” Psychopharmacology, November 2018. Accessed August 2, 2019.
Li, Wei; Li, Qiang; Wang, Yarong; Zhu, Jia; Ye, Jianjun; Yan, Xuejiao; Li, Yongbin; Chen, Jiajie; Liu, Jierong; Li, Zhe; Wang, Wei; Liu, Yijun. “Methadone-induced Damage to White Matter Integrity in Methadone Maintenance Patients: A Longitudinal Self-control DTI Study.” Scientific Reports, January 2016. Accessed August 2, 2019.
Vestal-Laborde, Allison A.; Eschenroeder, Andrew C.; Bigbee, John W.; Robinson, Susan E.; Sato-Bigbee, Carmen. “The opioid system and brain development: methadone effects on the oligodendrocyte lineage and the early stages of myelination.” Developmental Neuroscience, August 2014. Accessed August 2, 2019.
Alderks, Cathie E. “Trends in The Use Of Methadone, Buprenorphine, And Extended-Release Naltrexone At Substance Abuse Treatment Facilities: 2003-2015 (Update).” Substance Abuse and Mental Health Services Administration. August 2017. Accessed August 3, 2019.
Faul, Mark; Bohm, Michele; Alexander, Caleb. “Methadone Prescribing and Overdose and the Association with Medicaid Preferred Drug List Policies – United States, 2007-2014.” Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, March 2017. Accessed August 3, 2019.
Substance Abuse and Mental Health Services Administration. “Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health.” September 2017. Accessed August 3, 2019.
National Early Drug Warning System. “Southeastern Florida (Miami Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017.” November 2017. Accessed August 3, 2019.